Newsletter | August 21, 2025

08.21.25 -- Production Of A Highly Concentrated mAb

INDUSTRY INSIGHTS

Production Of A Highly Concentrated Monoclonal Antibody

The production of a highly concentrated monoclonal antibody requires many process steps. Discover how to achieve a final mAb concentration above 200 g/L while maintaining critical quality attributes.

Get Proactive With Your Stability Program

Learn when and how to effectively plan your stability testing program, how to ensure the right assay selection, and how forced degradation/accelerated studies may fit into your overall plan.

FEATURED EDITORIAL

Here's What Limits AI's Outlook For Replacing Knowledge Workers

Even after AI developers clean up hallucinations and other short-term issues, a large-scale workforce replacement faces a few intractable obstacles.

AI Data Security: The 83% Compliance Gap Facing Pharmaceutical Companies

A new study reveals a shocking truth: only 17% of pharmaceutical companies — including many CDMOs — have implemented automated controls to prevent sensitive data from leaking through AI tools.

Environmental Monitoring Performance Qualification In New Drug Manufacturing Facilities

In setting up a new manufacturing facility, a robust process for environmental monitoring must be established and cleanrooms in the classified areas must be properly qualified. Here are critical considerations to keep in mind.

NEWS HEADLINES

BioDlink Accelerates Global Expansion With Bevacizumab Launch In Colombia And Pakistan

Lupin Announces Licensing Deal For Ranibizumab Biosimilar